Evidence map›Paper›PMID 37451330›Full record

ArticleProgress in neurobiology2023

Parallel neurodegenerative phenotypes in sporadic Parkinson's disease fibroblasts and midbrain dopamine neurons.

M J Corenblum, A McRobbie-Johnson, E Carruth, K Bernard, M Luo, L J Mandarino, S Peterson, M A Sans-Fuentes, D Billheimer, T Maley and 2 more

Abstract read
In one paragraph

Article in Progress in neurobiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Experimental Cell Models for Investigating Neurodegenerative Diseases.International journal of molecular sciences · 2024
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

M J CorenblumDepartment of Neurology, University of Arizona, Tucson, AZ, United States.
A McRobbie-JohnsonPhysiological Sciences Graduate Program, University of Arizona, Tucson, AZ, United States.
E CarruthPhysiology Undergraduate Program, University of Arizona, Tucson, AZ, United States.
K BernardPhysiological Sciences Graduate Program, University of Arizona, Tucson, AZ, United States.
M LuoDepartment of Medicine, University of Arizona, Tucson, AZ, United States.
L J MandarinoDepartment of Medicine, University of Arizona, Tucson, AZ, United States.
S PetersonStatistical Consulting Lab, BIO5 Institute, University of Arizona, Tucson, AZ, United States.
M A Sans-FuentesStatistical Consulting Lab, BIO5 Institute, University of Arizona, Tucson, AZ, United States.
D BillheimerStatistical Consulting Lab, BIO5 Institute, University of Arizona, Tucson, AZ, United States.
T MaleyPhysiological Sciences Graduate Program, University of Arizona, Tucson, AZ, United States.
E D EggersDepartments of Physiology and Biomedical Engineering, University of Arizona, Tucson, AZ, United States.
L MadhavanDepartment of Neurology, University of Arizona, Tucson, AZ, United States; Evelyn F McKnight Brain Institute and BIO5 Institute, University of Arizona, Tucson, AZ, United States. Electronic address: lmadhavan@arizona.edu.

Funding

Retinal Neuronal Signaling in Early DiabetesR01EY026027 · NEI · UNIVERSITY OF ARIZONA · PI EGGERS, ERIKA D. · 2016 to 2024
$2.9M
NEI NIH HHS R01 EY026027
6 · The paper itself

Abstract

Understanding the mechanisms causing Parkinson's disease (PD) is vital to the development of much needed early diagnostics and therapeutics for this debilitating condition. Here, we report cellular and molecular alterations in skin fibroblasts of late-onset sporadic PD subjects, that were recapitulated in matched induced pluripotent stem cell (iPSC)-derived midbrain dopamine (DA) neurons, reprogrammed from the same fibroblasts. Specific changes in growth, morphology, reactive oxygen species levels, mitochondrial function, and autophagy, were seen in both the PD fibroblasts and DA neurons, as compared to their respective controls. Additionally, significant alterations in alpha synuclein expression and electrical activity were also noted in the PD DA neurons. Interestingly, although the fibroblast and neuronal phenotypes were similar to each other, they differed in their nature and scale. Furthermore, statistical analysis revealed potential novel associations between various clinical measures of the PD subjects and the different fibroblast and neuronal data. In essence, these findings encapsulate spontaneous, in-tandem, disease-related phenotypes in both sporadic PD fibroblasts and iPSC-based DA neurons, from the same patient, and generates an innovative model to investigate PD mechanisms with a view towards rational disease stratification and precision treatments.

Indexed as

Induced Pluripotent Stem CellsParkinson Diseasealpha-SynucleinDopaminergic NeuronsFibroblastsHumansMesencephalonPhenotypealpha-SynucleinAgingHuman Induced Pluripotent Stem CellsMidbrain Dopamine NeuronsMitochondrial DysfunctionParkinson's diseaseSkin fibroblasts

Identifiers

PMID37451330
PMCPMC11249208

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.